FindTrial
Sign In

To screen the key lncRNA in the occurrence and development of luminal A breast cancer using RNA-seq

To screen the key lncRNA in the occurrence and development of luminal A breast cancer using RNA-seq

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-BON-17011204
Enrollment
Unknown
Registered
2017-04-20
Start date
2017-04-13
Completion date
Unknown
Last updated
2017-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

LuminalA type breast cancer:Collecte the fresh luminalA type breast cancer tissue
LuminalA type breast cancer:Collecte the fresh luminalA type breast cancer adjacent tissues

Sponsors

People's Hospital of Deyang City
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) patients with definitive diagnosis of luminal type A breast cancer; (2) patients with early luminal type A breast cancer (TNM stage I / II without metastasis); (3) patients were not treated with chemotherapy before radiotherapy Treatment; (4) patients older than 18 years of age.

Exclusion criteria

Exclusion criteria: (1) patients with a history of cancer who were diagnosed with other tumors at the time of diagnosis; (2) patients with luminal A breast cancer diagnosed with TNMIII and stage IV; (3) breast cancer patients diagnosed with other subtypes.

Design outcomes

Primary

MeasureTime frame
Luminal type A breast cancer lncRNA expression profile;Luminal type A breast cancer miRNA expression profile;—

Countries

China

Contacts

Public ContactXingjian Jia

People's Hospital of Deyang City

dyjiaxj@163.com+86 0838-2418683

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026